3ea7c0a233f29cbcf1f7303baf22cffb *DESCRIPTION
2b564e9694782852678c195982c2a55f *INDEX
ad84159ae9fe99b4cb7d3b8ba96984df *LICENSE
f3b8533869343d7d34f978e7f371f86e *Meta/Rd.rds
4f63325db579cdae71c1eb8b95295dce *Meta/data.rds
f4c021eb699b03d5c65ae4ebc6fa3c2d *Meta/features.rds
ea21da229745b5c220457258eca01fdb *Meta/hsearch.rds
c891c550f551c0f181b9627c66f8b537 *Meta/links.rds
5cfb67fd43f5a2aab91306daf03821ec *Meta/nsInfo.rds
3d8aeee2299eb900feb5894109050bcc *Meta/package.rds
ccaae7171e0d4e5e8431a2eb4d792bb7 *NAMESPACE
d41d8cd98f00b204e9800998ecf8427e *NEWS
323c0e9dee7cf92f645140fcc5fc9e17 *NEWS.md
d6c68f1fe41ced6e98a766a3757313da *R/polypharmacy
5ce145056eb210441ab433ea9e9ebbdc *R/polypharmacy.rdb
c7c370a1c89b09eb9a00e0a262dc278c *R/polypharmacy.rdx
d83c9e428747e114090af65352e6864c *R/sysdata.rdb
81a4ca8adf3370959d72a1651cef9d10 *R/sysdata.rdx
d6029bca8b36a203b5c536161edcac12 *data/Rdata.rdb
30b5348260f650a4877b34ff806c5cb5 *data/Rdata.rds
400bf9deed765422734c99cb00835b80 *data/Rdata.rdx
4d88c81342a9a1e48d8cb85b07fd2b89 *extdata/Tableaux_de_references_criteres_selection_CS_2018-10-08.xlsx
5220036beb519e3832f4bb854ae919d6 *help/AnIndex
cd9072440a6ffab13368c5e23e198c23 *help/aliases.rds
45507e0cc2c703a717a00d5a74141adc *help/paths.rds
6abe08e7eb4b671676ba0956e0ca0c3e *help/polypharmacy.rdb
86dc9269f30b3b16456674ad775f4147 *help/polypharmacy.rdx
910171a905055d4a825ed1507b0e67d4 *html/00Index.html
8b9362669af13540a86a3ac6cf22f99d *html/R.css
